In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Transition Therapeutics Inc.

Latest From Transition Therapeutics Inc.

Gilead’s Magrolimab Hit With Third Clinical Hold, This Time In AML

Gilead’s novel immune checkpoint inhibitor candidate, magrolimab, has been placed on a partial clinical hold by the US Food and Drug Administration in acute myeloid leukemia, adding to a spate of recent setbacks for the therapy that are chipping away at investor confidence.

Clinical Trials ImmunoOncology

Brii Ups Its Bet On VBI’s Hepatitis B Assets Amid Larger Treatment, Prevention Push

The two companies have partnered on VBI-2601 since 2018, and Brii is now taking global rights to that program as well as licensing rights to VBI’s hepatitis B vaccine.

Deals Asia Pacific

Ex-Novartis Oncology Leader Riva Takes On Challenge Of Transgene Turnaround

After AstraZeneca walked away from a oncolytic virus vaccine partnership in May, French biotech Transgene was in sore need of a new direction. Enter new CEO Alessandro Riva, a man determined to deliver a proof of concept for the company.

Commercial Companies

Creating Best In Class Antivirals In Post-COVID China: Interview with Huahui Health CSO Li Wenhui

COVID-19 has highlighted the need for potent, safe and effective antiviral therapies for infectious diseases and now one well-known Chinese researcher is tackling hepatitis B and D though a homegrown drug discovery approach. He talks to Scrip in this wide-ranging audio interview.  

China Research & Development
See All

Company Information

  • Industry
  • Services
  • Other Names / Subsidiaries
    • Waratah Pharmaceuticals Inc.